Blood test may help tell MS from look-alike diseases

Credibility

Interest

Share:1 min read

Key Takeaway

Repeated blood tests found high levels of certain virus antibodies much more often in people with MS than in people with two look-alike conditions.

What They Found

Researchers looked for antibodies (proteins the immune system makes in response to germs) against the Epstein-Barr virus. High levels appeared repeatedly in about 96% of people with MS in the first group. They appeared repeatedly in about 8% of people with MOG antibody disease (a condition that can be mistaken for MS). They appeared repeatedly in about 18% of people with neuromyelitis optica (another condition that can be mistaken for MS). A second group showed a similar pattern.

Who Should Care and Why

The study included people with MS, people with two conditions that can look like MS, and healthy volunteers. The researchers focused on whether repeated blood samples could help tell these conditions apart. This can be difficult because their symptoms and brain scans can overlap. The blood test showed a similar pattern in two separate groups of patients. The findings suggest it may help doctors distinguish MS from these look-alike conditions.

Important Considerations

You should know this was a review of earlier patient records, not a trial of the blood test in routine care. The study included 2,091 patients and 1,976 healthy volunteers, but the two groups assessed with repeated samples included 493 patients. You cannot tell from this study whether the test would improve a diagnosis in routine care.

AI-generated summary — for informational purposes only, not medical advice

Categories:

MS Diagnostics

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like JAMA neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News